Amplia opens new front in ovarian cancer fight

Health

What to know

  • Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.S1S2
Timeline · newest first
1mo Theage · 2 reports

Amplia opens new front in ovarian cancer fight

Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.

Amplia opens new front in ovarian cancer fight